News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

State of Weill Cornell Medicine: A Bright Future

1300 York Avenue

Amid a changing and challenging time for academic medicine, Weill Cornell Medicine is poised to thrive in the coming years, with a planned expansion of its clinical enterprise serving as an engine for overall institutional growth, Dean Robert Harrington conveyed Dec. 16 during his biannual State of Weill Cornell Medicine address.

Weill Cornell, like many academic research institutions nationwide, has navigated financial uncertainty stemming from rapidly changing federal research support. But these challenges also revealed an opportunity to evaluate Weill Cornell’s core strengths—culminating in a plan to create the “academic medical center of the future,” said Dr. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University.

“I know this has been a tough year, but I’m also optimistic about the future,” he said. “And I’m especially optimistic because of the quality of the people that we have working across every domain: clinical, research and education.”

Microbiome May Aid in Successful Pregnancies

AI-generated image of intestines with microbes superimposed

Gut microbes may play a key role in training a mother’s immune system to adapt to the developing fetus during pregnancy, according to a preclinical study by Weill Cornell Medicine investigators.

The findings, published Dec. 17 in Cell, show that beneficial gut bacteria help prevent immune system reactions that can lead to pregnancy loss in mice. The investigators demonstrated that metabolites produced by gut microbes promote the recruitment of two types of protective immune cells, called myeloid-derived suppressor cells (MDSCs) and RORyt+ regulatory T-cells (pTregs), to the placenta and help the mother’s immune system learn to tolerate the fetus.

headshot of a woman

Dr. Melody Zeng

Breaking the Silence on Women’s Pelvic Floor Disorders

Dr. Larissa Rodriguez urologist

Many women assume pelvic floor health issues are simply their fate—part of having vaginal deliveries, getting older, gaining weight or entering menopause. Perhaps they have watched their mothers and grandmothers live with symptoms, such as urinary incontinence and pain. Though pelvic floor disorders happen when the muscles and tissues that support the bladder, bowel and uterus weaken or don’t work properly, they are not a normal part of aging.

But the misconception—that nothing can be done—keeps women from seeking help.

“There are so many people suffering from this, but people don't talk about it and are often embarrassed,” said Dr. Larissa Rodríguez, chair of the Department of Urology and the James J. Colt Professor of Urology at Weill Cornell Medicine and urologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center.

Part of the issue is making sure women know that treatments exist: pelvic floor physical therapy, behavioral strategies, medications, devices, procedures and vaginal estrogen, which can reduce urinary tract infections and improve urgency symptoms. In the absence of a well-known spokesperson who can raise awareness about pelvic floor disorders and inspire fundraising for research, Dr. Rodríguez spends time educating women and empowering them to talk to their doctors and seek treatment.